GILD FDA play this week 5/10/2012 GILD Gilead Sciences Inc. Truvada (sNDA) FDA panel to review Truvada in new indication as HIV preventive therapy 5/11/2012 GILD Gilead Sciences Inc. Quad (NDA) FDA panel to review Quad in potential treatmentof HIV stockcharts.com/c-sc/sc?s=GILD&p=D&yr=0&mn=6&dy=0&i=p06882736365&a=266438715&r=1336314427321